$IEX

Mizuho identifies five top industrial and electrical equipment stocks ahead of Q3 2026 earnings, citing strong fundamentals and order momentum. IDEX (IEX) is rated Outperform with a $280 target, expecting 5-7% organic growth. Eaton (ETN) anticipates 13.5-15.5% growth, while Emerson (EMR) faces a $25M headwind. Applied Industrial (AIT) and Dover (DOV) also receive Outperform ratings with growth expectations.

Mizuho keeps Idex as its top pick for semiconductor growth, citing TSMC's strong AI-driven Q3 2026 results and raised revenue forecast. TSMC expects $60B-$64B in 2026 capex, with 2026-2028 spending exceeding prior years. Mizuho highlights Idex, Parker-Hannifin, and Ametek as direct beneficiaries. Parker-Hannifin completed a $9.25B acquisition, with mixed analyst ratings and price targets.

Zacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.

IEX Group launched a vendor partnership program to expand access to its market data, offering revenue sharing for vendors. The program aims to support firms distributing IEX data and aligns with the growth of IEX's equities business. In Q2 2026, IEX had a 4% share of U.S. equity trading volume. The program includes IEX TOPS, DEEP, and DEEP+ products. According to IEX, vendors play a critical role in the market data ecosystem.

IDEX Corporation (IEX) amended its credit agreement, extending its debt maturity to 2031 with a $800 million revolving facility. The new agreement, led by Bank of America, provides financial flexibility for working capital and general corporate purposes. The company's GF Value is estimated at $226.10, with a GF Score of 94/100.

IDEX (IEX) reported strong Q2 earnings, record orders over $1B, and a 42.07% total shareholder return over the past year. Analysts' consensus price target is $254.50, with some valuing it higher at $280.0 and others lower at $215.0. Investors should monitor tariff pressures and sector demand.

IDEX CORP /DE/ (IEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, L. Paris Watts-Stanfield resigned from the Board of Directors (the “Board”) of IDEX Corporation (the

IDEX (IEX) reported Q2 2026 net sales of $920.6 million, up 6% reported and 5% organic. Adjusted diluted EPS rose 12% to $2.32. Orders were $1,071.6 million, a record, up 29% reported and 28% organic. Full-year 2026 guidance was raised: organic growth 5% to 6% and EPS $8.70 to $8.85.

The article compares Q2 results for industrial fluid-handling firms. Graco (GGG) reported $590.6M revenue, up 3.3% YoY, but 3% below analyst expectations. Flowserve (FLS) posted $1.17B revenue, down 1.6% YoY, beating forecasts by 0.9%, with mixed guidance. IDEX (IEX) had $920.6M revenue, up 6.4% YoY, beating by 1.7%.

24/7 Wall St. lists Wednesday analyst research calls. Upgrades include Hilton (HLT) to Buy with a $365 target, Intuitive Surgical (ISRG) to Outperform with a $500 target, Merck (MRK) to Outperform with a $143 target, and Okta (OKTA) to Outperform with a $170 target. Downgrades include The Gap (GAP) to Hold, and Novo Nordisk (NVO) to Hold. Initiations cover Genmab (GMAB) and Marriott (MAR).